Susan Hasty, Publisher
Table of Contents . . . July 28th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Biotech Business Week | Other Publications
Hormone Replacement Therapy - Application filed for generic Premarin
Nutrition - Omega-3 fatty acids formulated as stable, dry powder
Advanced Leukemia - Enrollment begins for phase I trial of SAHA
Embolic Protection - Company announces Proxis trial, distribution agreement, and financing
Generics - Generic biopharmaceuticals to hit market over next several years
Stroke - Early intervention with Atacand improves outcome
Atherosclerosis - Enrollment commences in pivotal ARISE phase III trial of AGI-1067
Blood Banking - Seven orders received for bioarchive systems in fourth quarter
Clinical Trials - VaxGen to complete phase III trial in Thailand
Finance - Pharmaceutical firm initiates actions to improve profitability
Gene Sequencing - DNASIS MAX 2.0 sequencing software new customizable workflow released
Market Analysis - Pharma leaders cut years off drug development time
Market Analysis - Pharmacist shortage continues unabated
Mergers and Acquisitions - Tender offer for all outstanding shares of pharmaceutical firm expires
Migraine Trends - Drug market to double from $2.86 billion in 2002 to $5.6 billion in 2012
Multiple Sclerosis - Avonex prefilled syringe approved in Europe
Pharmaceutical Trends - Study offers three cases modeling prescription brand impact
Stock Market - Blood analysis system manufacturer named to Russell 2000, Russell 3000 indexes
Stock Market - STAAR Surgical now listed on equity index
Stroke Prevention - Medtronic enters collaboration with Israeli company
Supplements - Tyson Foods to produce glucosamine and chondroitin ingredients
Traumatic Brain Injury - U.S. enrollment initiated in phase III study of dexanabinol
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.